688399 碩世生物
按盤價 
64.070 -11.010 (-14.664%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.101 | -0.060 | -10.408 | 57.894 | 56.807 |
| 總資產報酬率 ROA (%) | 0.085 | -0.052 | -8.498 | 43.572 | 41.309 |
| 投入資產回報率 ROIC (%) | 0.089 | -0.055 | -9.782 | 53.923 | 52.149 | 邊際利潤分析 |
| 銷售毛利率 (%) | 63.213 | 62.257 | 63.912 | 60.616 | 69.132 |
| 營業利潤率 (%) | 2.701 | 2.521 | -90.545 | 38.840 | 49.133 |
| 息稅前利潤/營業總收入 (%) | 3.474 | -8.234 | -105.007 | 38.025 | 48.281 |
| 淨利潤/營業總收入 (%) | 1.224 | -0.573 | -92.716 | 33.026 | 42.029 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -691.519 | -1,692.807 | 57.415 | 114.612 | 95.566 |
| 價值變動淨收益/利潤總額(%) | 522.632 | 19.870 | -3.914 | 2.418 | 2.116 |
| 營業外收支淨額/利潤總額(%) | 2.401 | -110.511 | 2.825 | -0.514 | -0.225 | 償債能力分析 |
| 流動比率 (X) | 3.318 | 5.816 | 7.447 | 3.977 | 2.967 |
| 速動比率 (X) | 3.219 | 5.634 | 7.189 | 3.724 | 2.675 |
| 資產負債率 (%) | 18.666 | 13.083 | 12.833 | 22.753 | 27.516 |
| 帶息債務/全部投入資本 (%) | 11.883 | 5.805 | 2.771 | 1.021 | 4.917 |
| 股東權益/帶息債務 (%) | 715.113 | 1,564.244 | 3,372.064 | 9,250.397 | 1,855.366 |
| 股東權益/負債合計 (%) | 435.743 | 664.322 | 679.242 | 339.502 | 263.420 |
| 利息保障倍數 (X) | 4.915 | 0.873 | 8.876 | -61.704 | -65.049 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 54.821 | 83.684 | 300.336 | 29.483 | 31.703 |
| 存貨周轉天數 (天) | 171.296 | 219.492 | 408.401 | 40.182 | 84.872 |
| 備註： | 即時報價更新時間為 17/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
